AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Atezolizumab
Sponsor: The Netherlands Cancer Institute
Collaborators: Roche Pharma AG